Biotech Medicilon congratulated AnDiCon Biotech collaborated with Simcere Pharmaceuticals to accelerate the commercialization of a new generation of anti-influenza drug ADC189 Bymedicilon November 8, 2023
Biotech Successful registration of ABSL-2 laboratory! Medicilon becomes a one-stop biopharmaceutical preclinical CRO with both ABSL-2 and BSL-2 laboratories Bymedicilon November 8, 2023
Biotech Medicilon was selected as “2023 Science and Technology Innovation Board Hard and Core Technology Leading Enterprise” Bymedicilon October 25, 2023
